{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T00:24:33Z","timestamp":1714177473635},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,4,26]]},"DOI":"10.7759\/cureus.59044","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:52:31Z","timestamp":1714117951000},"source":"Crossref","is-referenced-by-count":0,"title":["Gene Mutations Associated With Chronic Lymphocytic Leukemia (CLL) Among Saudi CLL Patients and Treatment Outcomes: A Single-Center Experience"],"prefix":"10.7759","author":[{"given":"Mohammed A","family":"Alsayari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giamal Edein M","family":"Gmati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamir","family":"Omair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Alhobabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faisal  T","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed  A","family":"Almutairi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al Waleed K","family":"Al Faifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Treatment of Cancer. 6th Edn","author":"Price P","year":"2014","unstructured":"Price P, Sikora K. Treatment of Cancer. 6th Edn. CRC Press, Boca Raton, Florida; 2014."},{"key":"ref2","article-title":"Chronic lymphocytic leukemia","author":"Perry MC","year":"2012","unstructured":"Perry MC, Doll DDC, Freter CE. Chronic lymphocytic leukemia. Perry\u2019s The Chemotherapy Source Book. Wolters Kluwer Health, Philadelphia, Pennsylvania; 2012. 599-603."},{"key":"ref3","unstructured":"Lymphoma Coalition Europe. (2022). https.\/\/lymphomacoalition.org\/europe\/."},{"key":"ref4","unstructured":"Leukemia - chronic lymphocytic - CLL. statistics. (2022). https:\/\/www.cancer.net\/cancer-types\/leukemia-chronic-lymphocytic-cll\/statistics."},{"key":"ref5","article-title":"Manual of Clinical Oncology","author":"Territo MC","year":"2017","unstructured":"Territo MC, Chmielowski B. Manual of Clinical Oncology. Wolters Kluwer Health, Philadelphia, Pennsylvania; 2017."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5897-5","article-title":"The burden of leukemia in the Kingdom of Saudi Arabia: 15\u2009years period (1999-2013)","volume":"19","author":"Bawazir A","year":"2019","unstructured":"Bawazir A, Al-Zamel N, Amen A, Akiel MA, Alhawiti NM, Alshehri A. The burden of leukemia in the Kingdom of Saudi Arabia: 15\u2009years period (1999-2013). BMC Cancer. 2019, 19:703. 10.1186\/s12885-019-5897-5","journal-title":"BMC Cancer"},{"key":"ref7","article-title":"Basics of Oncology","author":"Stephens FO","year":"2016","unstructured":"Stephens FO, Aigner KR. Basics of Oncology. Springer International Publishing, Cham, Switzerland; 2016."},{"key":"ref8","article-title":"Molecular Testing in Cancer","author":"Yousef GM","year":"2016","unstructured":"Yousef GM, Jothy S. Molecular Testing in Cancer. Springer, New York, NY; 2016."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-09-873083","article-title":"Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact","volume":"133","author":"Baliakas P","year":"2019","unstructured":"Baliakas P, Jeromin S, Iskas M, et al.. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact. Blood. 2019, 133:1205-16. 10.1182\/blood-2018-09-873083","journal-title":"Blood"},{"key":"ref10","unstructured":"TP53 genetic test. MedlinePlus. (2020). Accessed. November 28, 2020: https:\/\/medlineplus.gov\/lab-tests\/tp53-genetic-test\/."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial","volume":"123","author":"Stilgenbauer S","year":"2014","unstructured":"Stilgenbauer S, Schnaiter A, Paschka P, et al.. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood. 2014, 123:3247-54. 10.1182\/blood-2014-01-546150","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek M","year":"2008","unstructured":"Hallek M, Cheson BD, Catovsky D, et al.. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood. 2008, 111:5446-56. 10.1182\/blood-2007-06-093906","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25595","article-title":"Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment","volume":"94","author":"Hallek M","year":"2019","unstructured":"Hallek M. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. Am J Hematol. 2019, 94:1266-87. 10.1002\/ajh.25595","journal-title":"Am J Hematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.4103\/joah.joah_27_18","article-title":"B-Cell chronic lymphocytic leukemia fluorescence in situ hybridization panel findings at tertiary care hospital in Saudi Arabia","volume":"9","author":"Rawas W","year":"2018","unstructured":"Rawas W, Khalil S, Ghabashi E. B-Cell chronic lymphocytic leukemia fluorescence in situ hybridization panel findings at tertiary care hospital in Saudi Arabia. J Appl Hematol. 2018, 9:81. 10.4103\/joah.joah_27_18","journal-title":"J Appl Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"D\u00f6hner H","year":"2000","unstructured":"D\u00f6hner H, Stilgenbauer S, Benner A, et al.. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000, 343:1910-6. 10.1056\/NEJM200012283432602","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.885150","article-title":"Distinct age-related clinical features and risk assessment in Chinese with chronic Lymphocytic leukemia","volume":"12","author":"Tian Z","year":"2022","unstructured":"Tian Z, Liu M, Fang X, et al.. Distinct age-related clinical features and risk assessment in Chinese with chronic Lymphocytic leukemia. Front Oncol. 2022, 12:885150. 10.3389\/fonc.2022.885150","journal-title":"Front Oncol"},{"key":"ref17","article-title":"Cytogenetics in chronic lymphocytic leukemia","volume":"25","author":"Juliusson G","year":"1998","unstructured":"Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin Oncol. 1998, 25:19-26.","journal-title":"Semin Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13102468","article-title":"Current treatment options in CLL","volume":"13","author":"Bewarder M","year":"2021","unstructured":"Bewarder M, Stilgenbauer S, Thurner L, Kaddu-Mulindwa D. Current treatment options in CLL. Cancers (Basel). 2021, 13:2468. 10.3390\/cancers13102468","journal-title":"Cancers (Basel)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V114.22.535.535","article-title":"First-line treatment with fludarabine (F), cyclophosphamide (C), and rituximab (R) (FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic leukemia (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL study group","volume":"114","author":"Hallek M","year":"2009","unstructured":"Hallek M, Fingerle-Rowson G, Fink AM, et al.. First-line treatment with fludarabine (F), cyclophosphamide (C), and rituximab (R) (FCR) improves overall survival (OS) in previously untreated patients (pts) with advanced chronic lymphocytic leukemia (CLL): results of a randomized phase III trial on behalf of an international group of investigators and the German CLL study group. Blood. 2009, 114:535. 10.1182\/blood.V114.22.535.535","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/245063-gene-mutations-associated-with-chronic-lymphocytic-leukemia-cll-among-saudi-cll-patients-and-treatment-outcomes-a-single-center-experience","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:52:34Z","timestamp":1714117954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/245063-gene-mutations-associated-with-chronic-lymphocytic-leukemia-cll-among-saudi-cll-patients-and-treatment-outcomes-a-single-center-experience"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.59044","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4,26]]}}}